Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a Dual-Action supplement tame irritable bowel syndrome?

NCT ID NCT07716852

Not yet recruiting Disease control Sponsor: Gala Servicios Clinicos S.L. Source: ClinicalTrials.gov ↗

First seen Jul 21, 2026 · Last updated Jul 24, 2026 · Updated 3 times

Summary

This study tests whether a daily supplement called Enzymax DuoBiotics can ease symptoms of irritable bowel syndrome (IBS) in adults. The supplement combines digestive enzymes that break down food in the stomach with a probiotic and prebiotic that support gut bacteria in the intestines. Over 12 weeks, researchers will measure changes in symptom severity and quality of life in 120 participants, comparing the supplement to a placebo.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a dietary supplement containing digestive enzymes (lipase, protease, amylase, glucoamylase) and a probiotic (Lactobacillus plantarum) with prebiotic fiber (fructooligosaccharides)
What this could lead to
If it works, this supplement could offer a new option for managing IBS symptoms like bloating, pain, and irregular bowel habits.
What could go wrong
This is a small, early-stage trial with 120 people, and supplements often show limited benefit over placebo. Results may not apply to all IBS types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IRRITABLE BOWEL SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

irritable bowel syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IRRITABLE BOWEL SYNDROME IRRITABLE BOWEL SYNDROME (IBS)

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.